Safety and Pharmacokinetics of Ingavirin Forte, Capsules, 90 mg + 20 mg (Valenta Pharm JSC, Russia) Compared With Ingavirin, Capsules, 90 mg, Under Fasting and Fed Conditions.

NCT07645534 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

36

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza
Acute Respiratory Viral Infections

Interventions

DRUG: Ingavirin forte, capsules, 90 mg + 20 mg
DRUG: Ingavirin, capsules, 90 mg

Sponsor

Valenta Pharm JSC